Weight management refers to the multiple biological processes and psychological factors that contribute to an individual's capacity to acquire and maintain a specific weight. Many weight-loss techniques incorporate daily physical exercise and long-term dieting, which promote healthy eating among obese people. Geographically, North America appears to be gaining substantial traction in the weight reduction and weight management market. This is owing to high disposable income and the presence of a large patient pool throughout the United States. Furthermore, rising public awareness and an increase in the prevalence of health problems may boost regional market growth. On the other, Asia Pacific appears to be showing promising signals, with a surge in fitness awareness among people in India and China.
One of the most obvious reasons for the high adoption of weight management is rising burden of obesity and relevant chronic diseases. As per the World Health Organization (WHO), in 2016, over 1.9 billion adults aged 18 years and above were overweight, of which around 650 million were obese. As per the same source, in 2016, around 340 million children and adolescents aged 5-19 years were overweight or obese. This, in turn, can augment growth of the weight loss and weight management market.
Weight loss professionals examine numerous things that should be considered while developing a weight loss programme. The main focus of this treatment is on lifestyle, age, and genetic predisposition, which should not be overlooked. Some doctors offer weight loss strategies based on a certain genetic tendency. Despite these factors, several hurdles continue to exist and potentially stymie industry expansion. High expenses associated with low-calorie diets, for example, and deceptive marketing methods might stifle growth in the weight loss and weight management sector. Furthermore, restrictive product approval procedures may stifle market expansion.
Apart from high obesity rate, there are several other reasons for high adoption of weight loss programs. For instance, growing prevalence of lifestyle diseases such as hypertension, stress, and diabetes has increased the adoption of weight loss programs. As per the WHO, in 2021, around 1.13 billion people worldwide were living with hypertension, with the majority of the population from emerging economies. Therefore, such factors can stimulate growth of the weight loss and weight management market in the near future. Recently, in June 2021, Novo Nordisk received the U.S. Food and Drug Administration (FDA) approval for Wegovy injection for chronic weight management in adults with obesity or overweight.
No comments:
Post a Comment